The American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting is the world’s largest gathering of experts dedicated to reducing the global burden of tropical infectious diseases and improving global health. In 2025, the meeting will be held at the Metro Toronto Convention Centre from 9–13 November. Each year, ASTMH convenes thousands of researchers, clinicians, programme implementers, policymakers, and public‑health practitioners from over 100 countries to share the latest scientific advances, evidence, and innovations in tropical medicine.
Malaria remains one of the most pressing global health challenges. From drug and insecticide resistance to the rollout of new vaccines and diagnostics, ASTMH provides a critical platform for discussing solutions, fostering collaboration, and accelerating the translation of research into effective programmes in endemic settings.
This two-hour session will open with a live demonstration of Maisha ACT (Antimalarial Consumption Tracker), a dashboard tool that covers 80% of Africa’s antimalarial consumption across public and private sectors in 40+ countries. They will be showcasing insights on drug usage trends, key importers and exporters, pricing, quality, and more.
Second, they will be joined by an exceptional panel of researchers, government representatives, and NGOs, led by Dr. Maciej Boni (Temple University), to discuss the implications for novel data and research for drug-resistant malaria. Panelists will share their current work and latest findings about resistance, where data gaps persist, and how these insights can translate into tangible solutions.
Lastly, the session will also feature lightning talks on real-world use cases highlighting how novel data sources support market intelligence and strategic priorities— including tracking product launches, measuring and forecasting demand, assessing competitiveness, and analyzing price variations.
Jhpiego, implementing partner of Unitaid’s STOP-AMDR project, will join the panel discussion and share insights about the project.
Registration for this session is available here.
Overcoming barriers to the adoption of new radical cure tools will be pivotal to eliminating P. vivax malaria. P. vivax poses unique challenges to elimination given the lifecycle of the parasite and is globally relevant, impacting most tropical and sub-tropical areas of the world. New tools for radical cure hold promise for increasing patient adherence and reducing ongoing transmission, but their real-world implementation is complex. In presenting lessons learned from Brazil and insights from feasibility studies in Peru, PNG and Indonesia, the Symposium will be a conduit of information to countries helping them to prepare for or avoid altogether barriers to expanding access to P. vivax radical cure. Further, in presenting novel data on G6PD activity thresholds from across studies, the Symposium aims to demonstrate how adjusted thresholds and testing strategies may impact eligibility for improved, shorter-course radical cure.
Objectives:
The session will include:
New WHO guidance issued in 2023 recommended perennial malaria chemoprevention (PMC) as an intervention to prevent malaria in young children, encouraging countries to give more than three courses and increase the target age beyond children 12 months of age.
Drawing on evidence from the Unitaid-funded Plus Project and the Gates Foundation-funded PMC Effect project, speakers will share data on the operational feasibility, effectiveness, coverage, cost and cost-effectiveness of PMC.
Findings from the large-scale implementation of PMC in different epidemiological settings across Benin, Cameroon, Côte d’Ivoire, Mozambique and Nigeria are promising, providing practical lessons for policymakers. Speakers will discuss the implications of expanding PMC to other areas in these countries, as well as to other African nations.
The symposium will be co-chaired Malaria Consortium’s Chief Executive, Dr James Tibenderana, and Dr Corine Ngufor, Associate Professor at the London School of Hygiene & Tropical Medicine.
They will be joined by Dr Olusola Oresanya and Dr Chinazo Ujuju, Malaria Consortium Nigeria; Prof. Wilfred Mbacham, Fobang Institute for Innovation in Science and Technology; Dr Nnenna Ogbulafor, National Coordinator National Malaria Elimination Programme Nigeria; and Dr Shari Krishnaratne and Lucy Paintain, London School of Hygiene & Tropical Medicine.
